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ABSTRACT
Bone marrow stimulation may be applied to regenerate focal cartilage defects, but
generally results in transient clinical improvement and formation of fibrocartilage
rather than hyaline cartilage. Tissue engineering and regenerative medicine strive to
develop new solutions to regenerate hyaline cartilage tissue. This systematic review and
meta-analysis provides a comprehensive overview of current literature and assesses
the efficacy of articular cartilage regeneration by implantation of cell-laden versus
cell-free biomaterials in the knee and ankle joint in animals after bone marrow
stimulation. PubMed and EMBASE (via OvidSP) were systematically searched using
tissue engineering, cartilage and animals search strategies. Included were primary
studies in which cellular and acellular biomaterials were implanted after applying bone
marrow stimulation in the knee or ankle joint in healthy animals. Study characteristics
were tabulated and outcome data were collected for meta-analysis for studies applying
semi-quantitative histology as outcome measure (117 studies). Cartilage regeneration
was expressed on an absolute 0–100% scale and random effects meta-analyses were
performed. Implantation of cellular biomaterials significantly improved cartilage
regeneration by 18.6% compared to acellular biomaterials. No significant differences
were found between biomaterials loaded with stem cells and those loaded with
somatic cells. Culture conditions of cells did not affect cartilage regeneration. Cartilage
formation was reduced with adipose-derived stem cells compared to other cell types,
but still improved compared to acellular scaffolds. Assessment of the risk of bias
was impaired due to incomplete reporting for most studies. Implantation of cellular
biomaterials improves cartilage regeneration compared to acellular biomaterials.
Subjects Bioengineering, Evidence Based Medicine, Orthopedics, Rheumatology, Translational
Medicine
Keywords Cartilage, Biomaterials, Regenerative medicine, Cells, Microfracture
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INTRODUCTION
Articular cartilage facilitates joint loading and movement by resisting compressive
and shear forces (Swieszkowski et al., 2007). For patients, localized cartilage defects can
have detrimental long term effects such as joint dysfunction, pain, and degenerative
osteoarthritis. Upon cartilage damage, its avascular nature prevents spontaneous
healing (Buckwalter, Saltzman & Brown, 2004). Clinical treatments for full-thickness
cartilage defects and osteochondral lesions include bone marrow stimulation techniques,
e.g., microfracture and subchondral drilling, and autologous chondrocyte implantation.
Defect size generally determines treatment, where microfracture and autologous
chondrocyte implantation are used to treat small (<2.5 cm2) and large lesions (>2.5 cm2),
respectively (Cucchiarini et al., 2014). Microfracture surgery is a minimally invasive and
inexpensive one-step approach, where multiple perforations, microfractures, are made in
the subchondral bone plate to induce bleeding and provoke a reparative response. The
formed blood clot consists of bone marrow-derived mesenchymal stem cells (BM-MSCs),
growth factors and other proteins, supporting cartilage formation (Steadman, Rodkey &
Rodrigo, 2001). The repaired tissue, however, generally consists of fibrous cartilage, which
lacks the mechanical properties of native hyaline cartilage (Dai et al., 2014). Microfracture
results in temporary clinical improvement only (Saris et al., 2014), and the demand for
improved cartilage regeneration persists.
Cartilage regenerationmay be improved by tissue engineering and regenerativemedicine
(TERM) in addition to bone marrow stimulating techniques. TERM encompasses the
development of biomaterials, which can be loaded with cells and biologics (Seo et al., 2014).
Upon implantation and infiltration of BM-MSCs, the biomaterial may act as a template to
guide/stimulate cartilage regeneration (Cucchiarini et al., 2014). In a previous systematic re-
view andmeta-analysis on animalmodels, we showed that acellular biomaterials in addition
to bone marrow stimulation was more effective in regenerating cartilage in vivo than bone
marrow stimulation alone, whichwas further improved by use of biologics (Pot et al., 2016).
When biomaterials are loaded with cells, bone marrow stimulation may be even more
effective. Biomaterials loaded with cells after bone marrow stimulation has been widely
investigated in vivo, and included loading of chondrocytes (Ahn et al., 2009; Caminal et al.,
2016; Christensen et al., 2012), BM-MSCs (Araki et al., 2015; Igarashi et al., 2012; Wakitani
et al., 1994), synovium-derived mesenchymal stem cells (SD-MSCs) (Pei et al., 2009; Lee
et al., 2013; Shimomura et al., 2014), adipose-derived stem cells (ADSCs) (Xie et al., 2012;
Masuoka et al., 2006; Kang et al., 2014), periosteal cells (Perka et al., 2000; Schagemann et
al., 2009), fibroblasts (Yan & Yu, 2007), umbilical cord stem cells (UCSC) (Yan & Yu,
2007; Chung et al., 2014) and embryonic stem cells (ESC) (Cheng et al., 2014). Cells are
either used directly after harvesting (Betsch et al., 2014; Getgood et al., 2012) or after an
additional in vitro step of cell expansion (Guo et al., 2010; Dorotka et al., 2005) and/or
differentiation (Sosio et al., 2015; Necas et al., 2010).
In this systematic review and meta-analysis, we present a comprehensive overview of all
current literature regarding regeneration of articular cartilage by implantation of cell-laden
versus cell-free biomaterials in the knee and ankle joint after bonemarrow stimulation in an-
imalmodels (Fig. 1).We further investigated the effect of loading biomaterials with (1) stem
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Figure 1 Illustration of articular cartilage regeneration by implantation of cellular and acellular bio-
materials after applying bone marrow stimulation. The figure was adapted from Pot et al. (2016).
Full-size DOI: 10.7717/peerj.3927/fig-1
cells versus somatic (differentiated) cells, (2) different cell types (e.g., chondrocytes, MSCs,
ADSCs), and (3) culture conditions of cells (e.g., use after harvesting, in vitro expansion
and/or differentiation). In the meta-analysis, histological scores from semi-quantitative
histological scoring systems were used to assess the effect on cartilage regeneration.
MATERIALS AND METHODS
Search strategy
An extensive literature search was performed in PubMed and EMBASE (via OvidSP)
to identify relevant peer-reviewed articles until June 29, 2016, using methods
defined by De Vries et al. (2012) and Leenaars et al. (2012). The search strategy
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(Supplemental Information 1) consisted of search components for tissue engineering (Sloff
et al., 2014) and cartilage (Pot et al., 2016). Results were refined for animal studies by
applying animal search filters (Hooijmans et al., 2010; De Vries et al., 2011). No language
restrictions were applied.
Study selection
After obtaining all references, duplicates weremanually removed in EndNote X7 (Thomson
Reuters, Philadelphia, PA,USA) by one author (MP). Resulting references were screened for
relevance by two independent authors (MP and VG/WD) based on title, title/abstract and
full-text using Early Review Organizing Software (EROS, Institute of Clinical Effectiveness
and Health Policy, Buenos Aires, Argentina, http://www.eros-systematic-review.org).
In case of disagreement between authors or any doubt, references were included for
further screening. An overview of all exclusion criteria per screening phase is provided in
Supplemental Information 2.
Studies were included for risk of bias assessment and meta-analysis when semi-
quantitative histological scoring was used as outcome measure.
Study characteristics
Study characteristics were extracted from the studies by MP. Basic information (author,
year of publication), animal model characteristics (species, strain, sex, etc.), experimental
characteristics (surgery, biomaterial, follow-up, etc.), cell characteristics (cell type, culture
conditions, etc.) and outcome characteristics (macroscopic evaluation, histology and
semi-quantitative histological scoring, etc.) were obtained.
Risk of bias assessment
The methodological quality was assessed for studies included in the meta-analysis. A risk
of bias analysis was performed according to an adapted version (Pot et al., 2016) of the
tool described by Hooijmans et al. (2014). Selection, performance, detection and attrition
bias were scored independently by MP and VG/WD using questions and a flowchart (Pot
et al., 2016), where ‘-’, ‘?’ and ‘+’, indicating low, unknown and high risk of bias. In
case of differences between authors, results were discussed until consensus was reached.
Unfortunately, 16 articles were published in Chinese and we did not have the resources to
obtain certified translations of these articles. We were, however, able to successfully extract
the data of these studies using Google Translate (https://translate.google.com/) and used
the data in the meta-analysis. A sensitivity analysis was performed to evaluate the effect of
language (exclusion of Chinese articles, see ‘Meta-analysis’).
Analysis preparations and meta-analysis
Analysis preparations
Meta-analyses were performed for outcome measure semi-quantitative histology; data
were used from studies that compared biomaterials with (experimental group) and
without cells (control group). In general, these histological scoring systems and their
components, extensively reviewed by Rutgers et al. (2010), evaluate the degree of cartilage
regeneration by scoring parameters like Safranin-O staining (which stains negatively
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charged glycosaminoglycans, an important component of cartilage tissue), surface integrity
and cartilage thickness.
Outcome data (mean, standard deviation (SD) and number of animals) were extracted
from the studies for all time points as follows: (1) numerical data from the text/tables, (2)
graphical results by measuring the mean and SD using ImageJ (1.46r, National Institutes
of Health USA), (3), boxplot results by recalculating from median, range and sample size
to mean and SD (Hozo, Djulbegovic & Hozo, 2005), and (4) for results presented as mean
and confidence interval (CI) per group, the following equation was used to recalculate CI
to a standard deviation: SD=√N × upper limit−lower limit3.92 for a 95% CI (Higgins & Green,
2011). When data were missing or unclear, authors were contacted to provide data. Studies
were excluded from meta-analysis in case data could not be retrieved or remained unclear
(e.g., missing SD, all SD’s similar to corresponding mean, and histological scores exceeding
maximum), unless data were sufficiently clear to make assumptions (i.e., group size
and number of animals per time point and analyses, see Supplemental Information 3). A
sensitivity analysis was performed to evaluate the effect of assumptions (exclusion of articles
with assumptions, see ‘Meta-analysis’). Histological scoring systems describe the degree of
cartilage regeneration with different scoring scales. To compare data from different studies,
all data were converted to a 100% cartilage regeneration scale by dividing both themean and
SD by the maximum score of the scoring system and multiplying the outcome by 100%. In
this systematic review, healthy tissue is represented as 100% cartilage regeneration. Lower
percentages indicate less regenerated cartilage. When results of experimental groups could
be combined per study (i.e., outcome of various biomaterials seeded with one cell type),
we did so, followed the approach described in the Cochrane Handbook, table 7.7 (Higgins
& Green, 2011), which means that we calculated a weighted average of the results with an
appropriate standard deviation. Time points of treatment groups were combined using
the same approach. The mean and corresponding standard error (SE) per treatment group
were subsequently calculated per study.
Meta-analysis
Themain research questionwas: Is there an overall beneficial effect on cartilage regeneration
of implanting biomaterials loaded with cells compared to acellular biomaterials?
We used a bivariate approach to model a random effects meta-analysis, i.e., separate
outcomes for the control and experimental group were used with their respective SEs.
The correlation between these two outcomes was modeled with a compound symmetry
covariance matrix, as this resulted in a lower Akaike Information Criterion value than an
unstructured covariance matrix.
To evaluate the effect of specific variables on treatment outcome for the experimental
group (biomaterials loaded with cells), the following sub-questions were addressed: (1) Is
there a difference between the use of stem cells and somatic (differentiated) cells (stem cells
vs. somatic cells); (2) Do differences among various cell subgroups exist (e.g., chondrocytes
vs. other cells); (3) Is there a difference between biomaterials loaded with cells which were
not cultured in vitro, were expanded in vitro or were differentiated in vitro (during surgery
vs. expansion, surgery vs. differentiation, and expansion vs. differentiation)? Results are
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depicted as % cartilage regeneration (95% CI: [lower CI, upper CI]. The mean difference
(% [95% CI]) is presented as condition A–condition B. Based on a previous study, data
of all time points were used (Pot et al., 2016). Subgroup analyses were performed in case
subgroups consisted of more than five experimental groups in at least three studies. Most
studies contained more than one experimental group, therefore the total number of studies
and number of experimental groups (no. of studies/groups) is provided in the analysis. No
adjustment for multiple testing was applied in analyses of sub-questions.
Sensitivity analyses were performed on the main research question to evaluate the
effect of language (excluding Chinese articles, as the risk of bias for these articles was not
investigated), and the effect of assumptions (excluding articles for which assumptions were
made) in the meta-analysis.
SAS/STAT R© software version 9.2 for Windows, copyright c© 2002–2008 by SAS Institute
Inc., Cary, NC, USA, was used to perform statistical analyses. R software version 3.0.1 (R
Core Team, 2011) with package meta (Schwarzer, 2015) was used to create the funnel plot,
which illustrates effect sizes of all studies versus their precision, and test for the asymmetry,
using the method of moments estimator for the between study variation (Thompson &
Sharp, 1999). I 2 was used as a measure of heterogeneity. I 2 measures the percentage of
variability in treatment effect estimates that is due to between study heterogeneity rather
than chance (Higgins et al., 2003). If I 2 is 0%, this suggests that the variability in the study
estimates is entirely due to chance. If I 2 is >0% there might be other reasons for variability.
ReviewManager (The Cochrane Collaboration, 2014) was used to create the forest plot.
RESULTS
Search and study inclusion
Searching PubMed and EMBASE databases for references regarding cartilage regeneration
by implantation of cellular and acellular biomaterials in the knee and ankle joint in
combination with bone marrow stimulation resulted in a total of 11,248 references
(Pubmed 4,743, Embase 6,505). Removal of duplicates left 7,354 references. Screening by
title and title/abstract resulted in exclusion of 6,744 references. Full-text of 610 studies
resulted in 146 included studies. The full-text of some studies (Xie et al., 2014; Yao, Ma &
Zhang, 2000; Zhou & Yu, 2014) could not be retrieved and these were excluded.
In the meta-analysis, studies were used which applied semi-quantitative histology as
outcome measure, resulting in 117 included studies. A risk of bias assessment (Fig. 2) was
performed for 101 of 117 studies (excluding Chinese studies). Supplemental Information 3
provides an overview of all included studies after full-text screening, risk of bias assessment
and meta-analysis, as well as detailed information regarding reasons for exclusion and
assumptions made for certain studies. Supplemental Information 4 contains the reference
list and abbreviations of Supplemental Information 3 studies.
Study characteristics
A large variation between studies was observed regarding animal model characteristics
(species, strain, sex, etc.), experimental characteristics (surgery, biomaterial, follow-up,
etc.), cell characteristics (cell type, culture conditions, etc.) and outcome characteristics
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Figure 2 PRISMA (Preferred Reporting Items for Systematic Reviews andMeta-analysis) flowchart of
the systematic search of literature.Of the 117 studies included for the meta-analysis, a risk of bias assess-
ment was performed for 101 studies, excluding Chinese articles.
Full-size DOI: 10.7717/peerj.3927/fig-2
(macroscopic evaluation, histology and semi-quantitative histological scoring, etc.), as
can be appreciated from Supplemental Information 3. Various animal species were used
including rabbit, dog, sheep, pig, rat, horse, minipig, goat and macaques. A large range
was found in animal age, e.g., the age of rabbits ranged from six weeks to >2 years. Small
animals were generally younger (in the range of months) compared to larger animals (in
the range of years). In many studies, no detailed information was provided regarding the
animal’s absolute age, but merely e.g., adult or mature.
Themethod for bonemarrow stimulation wasmostly subchondral drilling (142 studies),
where only four studies used microfracture. Defects were created at various locations
(trochlea, condyles, femur and intercondylar fossa) and with diverse dimensions (e.g., for
rabbits: diameter 4–7 mm and depth 0.8–9 mm).
Implanted biomaterials were prepared from natural (e.g., alginate and collagen),
synthetic (e.g., poly(lactic-coglycolic acid) and polycaprolactone) or mixtures of natural
and synthetic materials. In 27 studies biologics, such as bone morphogenetic protein
2 and transforming growth factor beta, were loaded in the biomaterials. Different cell
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Figure 3 Results of the risk of bias analysis. Low, unknown or high risk of bias are presented in green,
orange and red, respectively, where the percentages indicate the percentage of studies scoring low, un-
known or high risk of bias of the total number of investigated studies per question. Low risk of bias was
mainly found for addressing incomplete outcome data and baseline characteristics at the moment of sur-
gical intervention. Unknown risk of bias was generally the result of limited details described in the studies
regarding the experimental set-up. High risk of bias was only occasionally scored. Questions 4–6 are not
depicted graphically, but are described and explained in Supplemental Information 4.
Full-size DOI: 10.7717/peerj.3927/fig-3
types were applied, including chondrocytes, bone marrow-derived mesenchymal stem
cells (BM-MSCs), bone marrow-derived progenitor cells, synovium-derived stem cells
(SD-MSCs), bone marrow-derived mononuclear cells, adipose-derived stem cells, adipose-
derived stromal vascular fraction cells, endothelial progenitor cells, embryonic stem cells,
umbilical cord blood stem cells, fibroblasts, and periosteal cells, while in some studies
undefined cell populations like bone marrow aspirate concentrate were used. Cells were
either seeded directly after harvesting on biomaterials and implanted in the created
defect or cultured in vitro to expand and/or differentiate the cells, followed by seeding on
biomaterials and implantation. In vitro differentiation was performed with cells cultured
in monolayer (without biomaterials), followed by seeding of the cells onto the biomaterials
and implantations, or by directly culturing the cells on biomaterials prior to implantation.
In most studies, short-term cartilage regeneration was investigated: the follow-up time
was generally less than 6 months with a maximum follow-up of 12 months.
Risk of bias assessment
Themethodological quality was assessed for all studies included in the meta-analysis except
Chinese articles. The overview of the results in Fig. 3 indicates a general lack of information
regarding the experimental setup of the studies, limiting the assessment of the actual risk
of bias. Please see Supplemental Information 5 for all scores per individual study.
In the assessed studies, details regarding the application and method of randomization
(Q1) were generally lacking. As a result, assessment of the actual risk of selection bias was
practically impossible. Assessment of the actual risk of bias due to differences in baseline
characteristics was difficult since no details regarding randomization were described.
Differences may have been present in load-bearing between implantation sites (Q2.1) and
age, sex and weight of animals (Q2.2). In most studies, few differences were found between
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animals at the moment of surgical intervention since animals were treated similarly (Q2.3).
Details regarding blinding of experimental conditions at the moment of implantation
were generally not provided, which may have resulted in bias (Q3). Random housing of
animals was generally not (well) described (Q4). Caregivers and/or investigators did not
know which intervention each animal received during the experiment (Q5). No details
were presented regarding the random selection of animals for outcome assessment (Q6).
The method of blinding during analysis, however, was well described in most studies (Q7).
Incomplete outcome data were identified or described in a few studies only, which resulted
in studies with high risk of bias (Q8). Generally, most studies lacked reporting of important
details and therefore adequate assessment of the actual risk of bias was difficult.
Data synthesis
Semi-quantitative histological scores were used as outcome data to compare biomaterials
with cells (experimental group) and without cells (control group) and to address sub-
questions related to the use of type of cells and culture conditions. An overview of all meta-
analysis results is provided in Table 1; an overview of all raw data is given in Supplemental
Information 6.
Data are presented as the effect (%) with 95% CI, where 100% cartilage regeneration
represents healthy tissue and lower percentages indicate less regenerated cartilage tissue.
Overall effect implantation of cellular and acellular biomaterials
The meta-analysis indicates that implantation of cellular and acellular biomaterials
resulted in 61.5% (95% CI [58.5–64.5]) and 43.0% (95% CI [40.0–46.0]) cartilage
regeneration, respectively. The addition of cells to biomaterials significantly improved
cartilage regeneration by 18.6% (95% CI [15.2–22.0], p< 0.0001). An overview of results
for each individual study is displayed in the forest plot (Supplemental Information 7),
presenting improved cartilage regeneration by loading biomaterials with cells in 66 studies,
similar cartilage regeneration in 30 studies, and a negative effect on cartilage regeneration
in two studies. The heterogeneity (I 2) for the comparison between cellular and acellular
biomaterials was very high (99.4% (95% CI [99.3%–99.4%])).
Stem cells and somatic cells
No significant differences (p= 0.622) were found between biomaterials loaded with stem
cells (61.5% (95% CI [58.1–65.0])) and somatic cells (62.8% (95% CI [58.5–67.1])).
Cell type
Biomaterials were loaded with various cell types. Subgroup analyses were only performed
when subgroups consisted of more than five experimental groups in at least 3 studies.
Seeding biomaterials with adipose-derived stem cells significantly decreased cartilage
regeneration, while no other significant differences were observed (Table 1). Only for
scaffolds seeded with adipose-derived stem cells (ADSCs), reduced cartilage regeneration
was found (56.3% (95%CI [49.9–62.6])) compared to cellular scaffolds. However, cartilage
regeneration using ADSCs-seeded scaffolds still improved regeneration compared to
acellular scaffolds.
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Table 1 Overviewmeta-analysis results; the effect on cartilage regeneration of (1) the addition of cells to biomaterials, (2) loading of stem cells
vs. somatic cells, (3) loading of specific cell types, e.g., chondrocytes vs. all cells except chondrocytes, and (4) culture conditions. The total num-
ber of studies and number of groups included in the meta-analysis are depicted (studies may have> 1 experimental group, no. of studies/groups).
Results are presented on a 100% cartilage regeneration scale, where 100% indicates ‘maximum’ cartilage regeneration. The addition of cells to bio-
materials significantly improved cartilage regeneration compared to acellular biomaterials. The use of stem cells or somatic cells resulted in com-
parable cartilage regeneration. Cartilage regeneration was significantly lower for biomaterials seeded with adipose-derived stem cells compared to
other cell types. Cartilage regeneration was not affected by the method of cell manipulation.
Meta-analysis No. of
studies/groups
Subgroups Cartilage regeneration
(% [95%CI)]
Mean difference
(% [95% CI])
p-value
98/265 Cellular scaffolds 61.5 [58.5–64.5] 18.6% [15.2–22.0]
1. Overall effect
98/208 Acellular scaffolds 43.0 [40.0–46.0] p< 0.0001
57/148 Stem cells 61.5 [58.1–65.0] −1.28 [−6.5–4.0]2. Stem cells
or somatic cells 36/101 Somatic cells 62.8 [58.5–67.1] p= 0.622
30/81 Chondrocytes 63.6 [58.1–69.0] 2.7 [−3.4–8.9]
p= 0.373
44/117 Bone marrow-derived MSCs 61.5 [57.1–65.9] −0.3 [−6.0–5.4]
p= 0.919
3/6 Synovium-derived MSCs 7.4 [36.7–98.2] −6.0 [−8.5–20.5]
p= 0.412
11/19 Adipose-derived stem cells 56.3 [49.9–62.6] −5.9 [−11.3–−0.4]
p= 0.036
8/14 Bone marrow aspirate 54.7 [39.8–69.6] −7.6 [−20.5–5.2]
p= 0.239
3/7 Bone marrow-derived mononuclear cells 74.1 [27.9–100.0] 12.9 [−8.6–34.3]
3. Type of cells
p= 0.238
14/27 During surgery: harvesting, implantation 58.9 [51.3–66.5] Surgery vs. Expansion
−2.4 [−10.8–5.9]
p= 0.564
59/180 Expansion: harvesting, expansion
in vitro, implantation
61.4 [57.6–65.1] Surgery vs. Differentiation
−4.2 [−13.5–5.1]
p= 0.374
27/58 Differentiation: harvesting, differentiation
in vitro, implantation
63.1 [57.6–68.6] Expansion vs. Differentiation
−1.7 [−8.2–4.7]
4. Cell
manipulation
p= 0.594
Cell manipulation
Comparing differences in cartilage regeneration between biomaterials loaded with cells
which were not cultured in vitro (implanted immediately after harvesting of cells) or were
expanded and/or differentiated in vitro indicated that cell manipulation did not affect
cartilage regeneration (Table 1).
Sensitivity analyses
To investigate the robustness of the meta-analysis, sensitivity analyses were performed
regarding the overall effect of the addition of cells to biomaterials. The overall outcome
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Figure 4 Funnel plot of the studies included in the meta-analysis comparing cartilage regeneration us-
ing cell-laden and acellular biomaterials.No substantial asymmetry was found.
Full-size DOI: 10.7717/peerj.3927/fig-4
effect for cellular scaffolds was not notably affected by the exclusion of studies (1) with
assumptions (2) or written in Chinese (no risk of bias assessment performed). Also for
acellular biomaterials, the exclusion of these studies had no effect on cartilage regeneration.
Publication bias
Publication bias was assessed for all studies included in the meta-analysis comparing
cartilage regeneration using acellular versus cellular biomaterials. Although the funnel plot
(Fig. 4) is rectangular in shape, no major asymmetry was observed, giving no indication
for publication bias (p-value 0.866).
DISCUSSION
Bone marrow stimulation can be applied to induce cartilage regeneration. Despite therapy,
the formed neotissue generally consists of fibrous cartilage, which lacks mechanical and
biological properties of native tissue (Dai et al., 2014). Therefore, microfracture results
in temporary clinical improvement only (Saris et al., 2014). To regenerate more durable
cartilage tissue, regenerative medicine and tissue engineering may offer a promising
addition to bone marrow stimulation by the implantation of scaffolds, which can act
as a template to guide and stimulate cartilage regeneration (Cucchiarini et al., 2014).
In a previous systematic review, the quality of newly formed cartilage in animals was
improved by the implantation of biomaterials after bone marrow stimulation, which was
further enhanced by loading biomaterials with biologics (Pot et al., 2016). The aim of
this systematic review was (a) to provide a comprehensive and systematic overview of all
current literature regarding animal studies on cartilage regeneration using cellular versus
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acellular biomaterials and to identify knowledge gaps, (b) to assess the efficacy of cartilage
regeneration using cellular versus acellular biomaterials and to investigate the effect of
various parameters (i.e., stem/somatic cells, cell source, cell culture conditions), (c) to gain
insight in the methodological quality of animal studies, and (d) to improve the design of
future animal models and eventually clinical trials.
In animal studies, the implantation of cellular biomaterials in animalmodels significantly
improved cartilage regeneration by 18.6% compared to acellular biomaterials. Seeding of
cells is a major component of the tissue engineering paradigm, which may stimulate
healing by the production of many bioactive components. Therefore, the addition of cells
to biomaterials enhanced the regenerative process (Wang et al., 2017). The heterogeneity
(I 2) for the main research question and subgroup analyses was very high. Results should
therefore be interpreted with caution, especially for subgroup analyses with a limited
number of studies. Further clinical studies are required to assess the potential beneficial
effect of cellular biomaterials versus acellular biomaterials in patients.Marcacci et al. (2005)
published promising results of a multicenter clinical phase III retrospective cohort study in
which patients were treated with an implant consisting of autologous chondrocytes grown
onHyalograft C, a hyaluronic acid derivative, with a 3-year follow-up. Assessment indicated
major clinical improvements and hyaline-like cartilage for the majority of biopsies.
In a subgroup analysis, no significant differences were found between somatic cells
and stem cells. Differences were found between various cell types. Adipose-derived stem
cells (ADSCs) reduced cartilage regeneration in the subgroup analysis. However, cartilage
regeneration using biomaterials seeded with ADSCs was still superior to biomaterials
without cells. As compared to other cell types, the origin of ADSCs from fatty tissue may
have resulted in significantly reduced cartilage regeneration compared to cells derived
from cartilage or subchondral bone. MSCs and chondrocytes have distinct advantages.
MSCs are not limited by donor-site morbidity and matrix production after expansion
in vitro (Bernhard & Vunjak-Novakovic, 2016), can be harvested from numerous sources,
maintain their multipotency after expansion in vitro, can differentiate into chondrocytes
that produce cartilage matrix and may suppress proinflammatory cytokines by their
immunoregulatory properties. Chondrocytes on the other hand do not terminally
differentiate after chondrogenic differentiation, which results in bone formation (Bernhard
& Vunjak-Novakovic, 2016), and are more easy to manipulate (Deng et al., 2016). In clinical
trials, the addition ofMSCs or chondrocytes to biomaterials resulted in comparable cartilage
regeneration (Nejadnik et al., 2010; Lee et al., 2012). In this study no subgroup analysis was
performed to investigate the culture of cell-loaded scaffolds in bioreactors. Bernhard &
Vunjak-Novakovic (2016) described the beneficial effects of culturing cell-loaded scaffolds
in bioreactors with mechanical loading protocols, as these scaffolds more closely resembled
the native compressive properties of cartilage tissue and as the applied force steered
the location and alignment of cartilage matrix deposition by chondrocytes (Bernhard &
Vunjak-Novakovic, 2016).
Study characteristics showed a large heterogeneity between studies due to differences in
animal model, performed surgery, implanted biomaterial and follow-up period. To reduce
the influence of possible confounding parameters, we excluded studies using healthy
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animals in which created defects were not filled during the first surgery and osteoarthritis
animal models, despite their greater relevance for future applications to treat patients with
osteoarthritis.
Various outcome measures were used to investigate cartilage regeneration, including
MRI, macroscopic and histological evaluation (more extensively discussed in Pot et al.,
2016). We selected data from semi-quantitative histological scoring systems as outcome
measure, because histological scores are frequently used and allow for quantitative
comparisons between studies. However, different scoring systems are available (extensively
reviewed by Rutgers et al. (Hooijmans et al., 2014)) that assess different processes, e.g.,
cartilage regeneration only, cartilage and subchondral bone regeneration, and additional
biomaterial degradation. Not discriminating between these parameters may be considered
as a limitation, but usage of all scoring systems may provide an extensive and complete
overview of all aspects affecting the regenerative process. Additionally, evaluation of
cartilage regeneration using semi-quantitative histological scoring may still be observer-
dependent and subjective, possibly inducing observer (detection) bias. Therefore, it may
be better to combine histological scores with biochemical parameters and biomechanical
properties, but the ideal combination of outcomeparameters remains unknown (Hooijmans
et al., 2014).
The methodological quality assessment was performed to evaluate the experimental
designs and reliability of the results of included studies. The methodological quality
(internal validity) is of great importance since a low methodological quality may result in
an overestimation or underestimation of the effect size (Higgins et al., 2011). No studies
were included in or excluded from the meta-analysis based on methodological quality
assessment results. Generally, the possibility of assessing the actual risk of bias was limited
due to the absence of important details regarding the experimental set-up in most studies
and method of randomization. It may be that the animal studies were performed well,
but that experimental designs were only reported poorly (Hooijmans et al., 2012). For the
analysis of the histological sections, however, most studies described that sections were
randomized and that outcome assessors were blinded. Detection/observer bias may be
introduced in case blinding was not performed and can result in an overestimation of
the actual effect of the therapy (Bello et al., 2014). The overall validity of the study results
may be impaired by bias due to the lack of blinding and randomization (Bebarta, Luyten
& Heard, 2003; Hirst et al., 2014). Reporting of animal studies may be improved by using
standardized protocols, including the ARRIVE guidelines (Kilkenny et al., 2012) or golden
standard publication checklist (Hooijmans et al., 2011).
A high translational value of animal studies is crucial to take treatments forward to
clinical practice. Therefore, validated and predictive animal models are required. Many
challenges and limitations are associated with the use of animal models for cartilage defects.
Chu, Szczodry & Bruno (2010) and Ahern et al. (2009) extensively described strengths and
shortcomings of different animal models related to e.g., joint size, cartilage thickness,
defect size, intrinsic healing potential and animal maturity, in comparison to lesions
in clinical studies. In most animal experiments, the follow-up period was maximally
six months, while in patients clinical improvements are generally observed up to 1.5–3
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years after microfracture surgery (Hoemann et al., 2010; Van der Linden et al., 2013). The
translational value and considerations to select animal models were extensively discussed
before (Pot et al., 2016).
Improved reporting of animal studies is required in future studies and studies should
strive to resemble the clinical situation to facilitate translation. For clinical application
of new regenerative medicine and tissue engineering strategies, including the use of
biomaterials, biologics and cells, the effectiveness needs to be proven both in animal
models and clinical studies (Cousin et al., 2016). Moreover, the cost-effectiveness of new
interventions in clinical practice may be assessed using early health economic models (De
Windt et al., in press). Considerations for the addition of cells to biomaterials are of great
importance and limitations (including donor-site morbidity, cell culture costs, regulatory
issues, limited off the shelf availability, and potentialmultiple-stage surgical procedures (Pot
et al., 2016; Efe et al., 2012)) should be weighed against potentially superior cartilage
regeneration by applying cellular biomaterials. Difficulties in controlling cell culture and
the development of novel materials stimulating tissue regeneration may justify the use
of acellular biomaterials. Future research focusing on biomaterials properties, source
and manipulation of cells, and possibly patient profiling, may allow selection of the best
treatment for each individual patient (Kon et al., 2015).
CONCLUSION
This systematic review and meta-analysis provides an extensive overview of all animal
studies applying regenerative medicine and tissue engineering approaches to regenerate
articular cartilage by implantation of cellular versus acellular biomaterials after applying
bone barrow stimulation. Cartilage regeneration was more effective by implantation
of cellular biomaterials compared to acellular biomaterials. This study together with a
previous study on the beneficial properties of scaffolds and growth factors implies that all
components of the tissue engineering paradigm can be valuable for improved regeneration
of articular cartilage.
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